Position in DNLI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$28,472
+$7,218 QoQ
Shares Held
1,107
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#219
of 290 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Smartleaf Asset Management LLC holds $9,783,497 across 140 Biotechnology names. DNLI ranks #45 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,540 | $2,255,154 | |
| 2 | CAI |
Caris Life Sciences, Inc.
|
94,051 | $1,675,988 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846 | $527,514 | |
| 4 | ARGX |
Argenx SE
|
463 | $429,557 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,361 | $409,701 | |
| 6 | TECH |
BIO-TECHNE Corp
|
4,639 | $327,745 | |
| 7 | ALLO |
Allogene Therapeutics, Inc.
|
137,874 | $286,777 | |
| 8 | GMAB |
Genmab A/S
|
8,399 | $230,720 |
All Filings in DNLI
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,472 | 1,107 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $21,254 | 1,107 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $21,677 | 1,313 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $13,852 | 954 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $6,351 | 454 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,430 | 473 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $21,704 | 1,065 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $19,400 | 666 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||